Marina Biotech president and chief executive officer Michael French said, "We view this license as yet another important validation of this platform and we look forward to a strong and growing relationship with Monsanto." Marina Biotech is focused on the development and commercialization of oligonucleotide-based...
FULL ARTICLE AT Pharmaceutical Industry News